semaglutide vision loss A new study published in the Open Access journal Pharmaceutics shows that semaglutide, also known as Ozempic, has therapeutic potential for protection against in people with diabetes. Diabetic retinopathy is Study: Ozempic linked to eye

An injection tracker tells you when you took your shot

Drinking alcohol with diabetes treatment could increase the risk of hypoglycemia or low blood sugar levels

Ozempic officially launched in India on December 12, 2025 by Novo Nordisk

Swiss pharmaceutical company Roche has reported promising Phase II trial results for Petrelintide, a once-weekly injection aimed at chronic weight management

Key Takeaways Yerba mate tea may help increase GLP-1 levels, which are important for appetite control

The interaction between semaglutide and alcohol is another practical concern, as many users report increased alcohol sensitivity and reduced tolerance while on GLP-1 agonists